Get started
Live feed
·
SECFilingvia Quantisnow
Summit Therapeutics Inc. logo

SMMT: Summit Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for SMMT

Across the 26 sessions after earlier SMMT headlines, the stock closed higher 10 times and lower 16 times, with a median move of 2.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

SMMT close-to-close change in the session after earlier headlines
SessionEarlier headlineSMMTSPY
Jul 22, 2026Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from Global Phase III HARMONi Study+0.8%-0.1%
Jul 16, 2026Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026-8.7%-0.5%
Jul 14, 2026Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.+1.1%+0.4%
Jun 10, 2026Summit Therapeutics Announces Proposed Public Offering of Common Stock-8.7%-1.6%
Jun 5, 2026Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference-0.5%-2.6%
Jun 1, 2026Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in Chinaand 1 other headline that session-10.4%+0.3%
Quantisnow market dataNASDAQ
Summit Therapeutics Inc. logo
SMMT
Summit Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2015
Get push alerts for SMMT

Follow SMMT and get a push notification the moment its next story breaks.

Full SMMT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SMMT (Summit Therapeutics Inc.) and more on Quantisnow.